Paper17569868
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V and 5 others. Science, 2007. Cited by 717 papers, by iCite.
Cite this record
ConductScience Library. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Papers, record 17569868. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17569868
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Vesicular Transport | Major topic |
| Adjuvants, Immunologic | Major topic |
| Lipid A | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Adoptive Transfer | |
| Animals | |
| Cytokines | |
| Immunization | |
| Lipopolysaccharides | |
| Lymphocyte Activation | |
| Macrophages | |
| Mice | |
| Mice, Inbred C57BL | |
| Monocytes | |
| Myeloid Differentiation Factor 88 | |
| Oligonucleotide Array Sequence Analysis | |
| Ovalbumin | |
| Phosphatidylinositol 3-Kinases | |
| Signal Transduction | |
| T-Lymphocytes |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI051377 | NIAID NIH HHS | United States | R01AI051377 | PubMed and NIH | NIH RePORTER |
| K02 AI059023 | NIAID NIH HHS | United States | K02AI059023 | PubMed and NIH | NIH RePORTER |
| AI51377 | NIAID NIH HHS | United States | R01AI051377 | PubMed and NIH | NIH RePORTER |
| R01 AI071047 | NIAID NIH HHS | United States | R01AI071047 | PubMed and NIH | NIH RePORTER |
| AI059023 | NIAID NIH HHS | United States | K02AI059023 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17569850 | Immunology. The shape of things to come. | https://conductscience.org/library/papers/17569850 |
Source PubMed
Cited by481
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 717 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851384 | Dissecting the mechanism of action of the adjuvant system AS01 in human immune cells: synergy of QS-21 and monophosphoryl lipid A and role of type I interferons. | Front Immunol | 2026 | https://conductscience.org/library/papers/42851384 | PubMed |
| 42682849 | Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42682849 | PubMed |
| 42657027 | Phosphorylation shapes antigen presentation and immune recognition: mechanistic insights and translational perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42657027 | PubMed |
| 42635620 | Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42635620 | PubMed |
| 42618767 | Bacterial lipid structural diversity mediates commensalism and pathogenesis. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/42618767 | PubMed |
| 42534843 | Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42534843 | PubMed |
| 42484648 | Outer membrane engineering through lipid A modification allows modulation of Burkholderia pseudomallei membrane permeability and innate immune responsivity. | Infect Immun | 2026 | https://conductscience.org/library/papers/42484648 | PubMed |
| 42475333 | Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency. | PLoS One | 2026 | https://conductscience.org/library/papers/42475333 | PubMed |
| 42188764 | Plant-Based Strategies for Vaccine Development: A Narrative Review of Recombinant Biofactories, Phytochemical Adjuvants, Innovative Delivery Systems, and Insights on Oral and Edible Vaccines. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188764 | PubMed |
| 42188757 | Bordetella pertussis Infection: From Immune Pathogenesis to Next-Generation Vaccines. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188757 | PubMed |
| 42094701 | Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42094701 | PubMed |
| 41983139 | Monophosphoryl lipid A boosts macrophage antimicrobial immunity by metabolically regulating source-specific ROS generation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41983139 | PubMed |
| 41837360 | Rational design of next-generation vaccine adjuvants: From molecular mechanisms to hybrid delivery platforms. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41837360 | PubMed |
| 41754498 | The Safety of Alcaligenes Lipid A in a Virus-Induced Immune Disease Model Associated with IgA, Th17 Cells, and Microbiota. | Viruses | 2026 | https://conductscience.org/library/papers/41754498 | PubMed |
| 41723190 | Self-destructing attenuated adjuvant Salmonella serves as a safe and potent live vaccine adjuvant. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41723190 | PubMed |
| 41625474 | Treatment of Metastatic Cancer by Conferring Immunogenicity to the Apoptotic Bodies of the Primary Tumor. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/41625474 | PubMed |
| 41601666 | Current update on toll-like receptors and prostate cancer: a decade of progress and emerging insights. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601666 | PubMed |
| 41529396 | Bioprinting collagenase-responsive hydrogel for controlled release of cowpea mosaic virus immunotherapy. | Biofabrication | 2026 | https://conductscience.org/library/papers/41529396 | PubMed |
| 41409277 | From bark to bench: innovations in QS-21 adjuvant characterization and manufacturing. | Front Immunol | 2025 | https://conductscience.org/library/papers/41409277 | PubMed |
| 41403359 | Programmable Antigen-Specific Immunity via Self-Adjuvanting Nanovaccines Co-Delivering Immune Modulators. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/41403359 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TICAM1 | 148022 | PubTator's text mining | https://conductscience.org/library/genes/148022 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17569868
GET https://conductscience.org/api/papers/v1/17569868/cited_by?page=2